Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

Presentation TCT 2025

TCT 497: Combined Assessment of Lipoprotein(a) and Non-Culprit Coronary LesionSeverity on Clinical Outcomes in Acute Coronary Syndrome

Presenter: Hirokazu Tanaka

October 28, 2025

Presentation TCT 2025

TCT 486: Lipoprotein(a) as a Predictor of Lesion Complexity in Patients undergoing Elective Percutaneous Coronary Intervention : Insights from an Asian single center cohort

Presenter: Melly Susanti

October 27, 2025

Presentation TCT 2025

TCT 485: Lipoprotein(a) and Long-Term Cardiovascular Events in Patients With Coronary Vasospasm

Presenter: Melly Susanti

October 27, 2025

Presentation TCT 2025

TCT 480: Imparied high-density lipoprotein functionality assessed by cholesterol uptake capacity might cause plaque vulnerability and unfavorable prognosis after percutaneous coronary intervention.

Presenter: Kotaro Higuchi

October 27, 2025

Presentation TCT 2025

TCT 475: Impact of Elevated Lipoprotein(a) on LDL Cholesterol Target Attainment Following PCI for Acute Coronary Syndrome Despite Intensive Triple Oral Lipid-Lowering Therapy: A Retrospective Cohort Study

Presenter: Kunal Mahajan

October 27, 2025

Presentation TCT 2025

TCT 1241: Atherogenic Lipoproteins and Intraplaque Lipid Burden: Evidence from NIRS-IVUS in Statin-Naive Patients

Presenter: Woohyeun Kim

October 26, 2025

Presentation AHA 2024

Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks

Presenter: Steven E. Nissen

November 18, 2024

Presentation TCT 2024

TCT 260: Lipoprotein (a) and Endoluminal Disease Phenotype

Presenter: TsungYing Tsai

October 30, 2024

Presentation TCT 2024

TCT 1019: Coronary Plaque Characteristics Assessed by Optical Coherence Tomography and Plasma Lipoprotein (a) Levels in Patients With Acute Coronary Syndrome

Presenter: Francesca Maria Di Muro

October 29, 2024

Presentation TCT 2024

I Measured Lipoprotein (a): What was I Thinking, and Now What Do I Do?

Presenter: Dipti Itchhaporia

October 29, 2024

Presentation TCT 2024

TCT 15: Impact of High Lipoprotein(a) Levels on 5-Year Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent in Korean Population

Presenter: Woo Jin Ahn

October 29, 2024

Presentation AHA 2023

Lepodisiran: An Extended-Duration siRNA Targeting Lipoprotein(a)

Presenter: Steven E. Nissen

November 11, 2023

Presentation TCT 2023

Lipoprotein(a): Why Measure and What to Do?

Presenter: Sotirios Tsimikas

October 26, 2023

Presentation TCT 2023

TCT 271: Characterizing pathophysiological patterns of coronary artery disease among Individuals with Elevated Lipoprotein(a).

Presenter: Mick Renkens

October 25, 2023

Presentation TCT 2023

TCT 1006: Significant multivessel disease in a very young patient presenting with ACS and extremely high lipoprotein (a): early recognition and how to revascularize?

Presenter: Lars Witte

October 25, 2023

Presentation TCT 2023

TCT 486: Achieving Low-Density Lipoprotein Cholesterol Goal and Very Long-Term Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention for Left Main Coronary Artery Disease

Presenter: Hong Nyun Kim

October 24, 2023

Presentation Complex Coronary Cases 2023

Lipoprotein(a): The New Kid on the Block

Presenter: Pam R. Taub

June 15, 2023

Presentation AHA 2022

Reduction of Lipoprotein(a) With Small Interfering RNA: Results of the OCEAN(a)-DOSE (TIMI 67) Trial

Presenter: Michelle L. O’Donoghue

November 07, 2022

Presentation TCT 2022

TCT 577: Lipoprotein (a) and Intracoronary Imaging After Intensive Statin Treatment

Presenter: Shingo Minatoguchi

September 19, 2022

Presentation TCT 2022

TCT 181: Effect of Lipoprotein(a) in Patients With Coronary Calcification Undergoing Percutaneous Coronary Intervention

Presenter: Deshan Yuan

September 18, 2022

Advertisement

TCT 497: Combined Assessment of Lipoprotein(a) and Non-Culprit Coronary LesionSeverity on Clinical Outcomes in Acute Coronary Syndrome

TCT 486: Lipoprotein(a) as a Predictor of Lesion Complexity in Patients undergoing Elective Percutaneous Coronary Intervention : Insights from an Asian single center cohort

TCT 485: Lipoprotein(a) and Long-Term Cardiovascular Events in Patients With Coronary Vasospasm

TCT 480: Imparied high-density lipoprotein functionality assessed by cholesterol uptake capacity might cause plaque vulnerability and unfavorable prognosis after percutaneous coronary intervention.

TCT 475: Impact of Elevated Lipoprotein(a) on LDL Cholesterol Target Attainment Following PCI for Acute Coronary Syndrome Despite Intensive Triple Oral Lipid-Lowering Therapy: A Retrospective Cohort Study

TCT 1241: Atherogenic Lipoproteins and Intraplaque Lipid Burden: Evidence from NIRS-IVUS in Statin-Naive Patients

Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks

TCT 260: Lipoprotein (a) and Endoluminal Disease Phenotype

TCT 1019: Coronary Plaque Characteristics Assessed by Optical Coherence Tomography and Plasma Lipoprotein (a) Levels in Patients With Acute Coronary Syndrome

I Measured Lipoprotein (a): What was I Thinking, and Now What Do I Do?

TCT 15: Impact of High Lipoprotein(a) Levels on 5-Year Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent in Korean Population

Lepodisiran: An Extended-Duration siRNA Targeting Lipoprotein(a)

Lipoprotein(a): Why Measure and What to Do?

TCT 271: Characterizing pathophysiological patterns of coronary artery disease among Individuals with Elevated Lipoprotein(a).

TCT 1006: Significant multivessel disease in a very young patient presenting with ACS and extremely high lipoprotein (a): early recognition and how to revascularize?

TCT 486: Achieving Low-Density Lipoprotein Cholesterol Goal and Very Long-Term Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention for Left Main Coronary Artery Disease

Lipoprotein(a): The New Kid on the Block

Reduction of Lipoprotein(a) With Small Interfering RNA: Results of the OCEAN(a)-DOSE (TIMI 67) Trial

TCT 577: Lipoprotein (a) and Intracoronary Imaging After Intensive Statin Treatment

TCT 181: Effect of Lipoprotein(a) in Patients With Coronary Calcification Undergoing Percutaneous Coronary Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content